mumps vaccine / Sinovac  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mumps vaccine / Sinovac
NCT05065177: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Completed
3
1140
RoW
Investigational live attenuated mumps vaccine, control live attenuated mumps vaccine
Sinovac Research and Development Co., Ltd.
Mumps
03/16
04/16
NCT02692599: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Completed
3
1150
RoW
investigational live attenuated mumps vaccine, control live attenuated mumps vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Mumps
03/16
07/16

Download Options